IMMUNOCOMPROMISED

Clinical trials for IMMUNOCOMPROMISED explained in plain language.

Never miss a new study

Get alerted when new IMMUNOCOMPROMISED trials appear

Sign up with your email to follow new studies for IMMUNOCOMPROMISED, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 2 Terminated 1

Shield for the vulnerable: antibody shots tested to block COVID in Immune-Weakened patients

Prevention Terminated

This study tested whether regular injections of lab-made antibodies (casirivimab+imdevimab) could prevent symptomatic COVID-19 in people with weakened immune systems. It involved 66 participants who were vaccinated but had a poor antibody response or couldn't get vaccinated. The …

Matched conditions: IMMUNOCOMPROMISED

Phase: PHASE3 • Sponsor: Regeneron Pharmaceuticals • Aim: Prevention

Last updated Mar 30, 2026 14:29 UTC

IMMUNOCOMPROMISED

Get alerted when new IMMUNOCOMPROMISED trials appear

Shield for the vulnerable: antibody shots tested to block COVID in Immune-Weakened patients